TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA)

Historical Holders from Q4 2019 to Q3 2025

Symbol
TELA on Nasdaq
CUSIP
872381108
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
44.5M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
23.6M
Holdings value
$35.1M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
40
Number of buys
11
Number of sells
-16
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
EW HEALTHCARE PARTNERS FUND 2, L.P. 17.32% $11.6M 7.71M EW Healthcare Partners Fund 2 GP, L.P. Nov 17, 2025
Nantahala Capital Management, LLC 12.9% +29.1% $5.26M $1.17M 5.11M +28.6% Nantahala Capital Management, LLC Apr 30, 2025
NORTH RUN CAPITAL, LP 9.3% $3.61M 3.68M North Run Capital, LP Mar 31, 2025
SILVERARC CAPITAL MANAGEMENT, LLC 7.8% $3.16M 3.07M SilverArc Capital Management, LLC Dec 31, 2024
LYTTON LAURENCE W 7.2% -14.4% $4.27M -$833K 2.87M -16.3% Lytton, Laurence W. Sep 30, 2025
Stonepine Capital Management, LLC 6% $2.42M 2.35M Stonepine Capital Management, LLC Dec 31, 2024
HIRSCHMAN ORIN 3.6% -45.7% $1.46M -$1.28M 1.42M -46.8% Orin Hirschman Mar 31, 2025

Institutional Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 23.6M $35.1M +$71K $1.49 40
2025 Q2 23.5M $45.5M -$776K $1.94 45
2025 Q1 24.6M $30M -$5.39M $1.22 47
2024 Q4 27M $81.6M +$27.8M $3.02 46
2024 Q3 18M $45.6M -$11M $2.53 48
2024 Q2 19.9M $93.4M -$6.73M $4.70 67
2024 Q1 20.7M $117M -$1.44M $5.67 58
2023 Q4 21M $139M -$8.56M $6.62 59
2023 Q3 21.9M $175M -$1.84M $8.00 66
2023 Q2 22.1M $223M +$51.5M $10.13 67
2023 Q1 16.9M $180M -$5.75M $10.64 54
2022 Q4 17.4M $200M +$6.25M $11.50 49
2022 Q3 16.8M $143M +$28.9M $8.52 43
2022 Q2 13.5M $95M +$21.1M $7.01 31
2022 Q1 0 $0 -$6.16M 0
2021 Q4 10.5M $135M -$161K $12.80 34
2021 Q3 10.2M $140M -$332K $13.66 36
2021 Q2 10.2M $165M +$6.14M $16.11 44
2021 Q1 9.89M $147M +$2.99M $14.90 46
2020 Q4 9.69M $146M -$989K $15.04 47
2020 Q3 9.75M $161M +$2.12M $16.54 43
2020 Q2 9.74M $126M +$40.3M $12.96 49
2020 Q1 6.48M $50.6M -$2.64M $7.82 26
2019 Q4 6.38M $82.7M +$79.1M $12.95 22